美年大健康產業控股股份有限公司（A 股：SZ002044）始創于 2004 年，是中國專業健康體檢和醫療服務集團，總部位于上海。美年健康已成功收購“美兆”、“慈銘”，完成中國版圖的全覆蓋（除港、澳、臺地區），實現布局全國 684 家專業體檢中心 （截止 2019 年 6月30日）。 全集團擁有專家團隊、醫護及管理人員共計70000余名員工。2018年為近3000萬人次提供專業健康服務。2018 年，美年健康納入 MSCI 指數，并獲得穆迪 BA2、惠譽BB+評分，得到國際高級別評級機構支持。美年健康現已成為中證 200 指數、滬深 300指數、中證 700 指數、中證 800 指數成分股，是醫療和大健康板塊中市值和影響力杰出的上市公司。
Meinian Onehealth Healthcare Holdings Co., Ltd.,（SZ：002044） incorporated in 2004, is a well-known professional health checkup and medical treatment service group in China, headquartered in Shanghai. The Group acquired MJ Health Care and Ciming respectively, formally completed full coverage in China (excluding Hong Kong, Macau and Taiwan), realizing a deployment of over 684 professional health checkup centers in China（As of 30 Jun. 2019）. The Group has a professional service force over 70,000 employees including full-time experts, medical personnel andmanagerial personnel. In 2018, the group has provided professional healthy service to appr.30 million person-times. In 2018, the Group was listed in MSCI. 19 of the same year, was rated Moody's BA2, Fitch BB+, and was supported by the internationally highest rating organization. Currently, Meinian Healthcare is the CSI 200 index, Shanghai and Shenzhen 300 index and CSI 700 index and CSI 800 index stock. The group established its position as a listed company with outstanding market share and influences in the medical treatment and enlarged health sector.
Meinian Healthcare Ecosphere also provides the all-round value added services such as special detection, gene detection, chronic disease management, remote medical treatment, female health, preventive treatment of disease, etc., in order to build the enlarged health industry cluster, with the ecosphere platform and incubation carrier function making Meinian Healthcare successfully building the health industrial core ecosphere with strong influences, and continuously devote itself to the development of the preventive medicine and the reforming of the health management industry.